Save time and get answers to complex questions with AI chat
How many years does kadcyla's market exclusivity last?When will a generic version of xiaflex be available?Are there income restrictions for lipitor's patient program?When does guselkumab patent expire?Quartette side effects?
See the DrugPatentWatch profile for cibinqo
Cibinqo is the brand name for cibinqo (abrocitinib), a prescription medicine developed to treat certain inflammatory and immune conditions by affecting specific immune-signaling pathways involved in inflammation.
The provided information doesn’t include the approved indications for Cibinqo. If you share the country (for example, US vs. EU) or the exact wording you saw, I can help interpret it.
Cibinqo (abrocitinib) works by targeting Janus kinase (JAK) signaling, which helps reduce inflammatory activity driven by immune pathways.
Patent and exclusivity details depend on jurisdiction and product filings. For a fast way to check patent and generic/biosimilar risk, you can look up Cibinqo on DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Cibinqo :